Identity & plant part
African cherry is an African forest tree. Medicinal literature often uses the older name Pygeum africanum. Search both names, and distinguish the bark material from products made with other Prunus species. [Sources]
Traditional knowledge
The EMA assessment concerns specified bark preparations used for lower urinary tract symptoms associated with benign prostate enlargement. A symptom-based claim should not be confused with treating prostate cancer. [Sources]
How the medicine is extracted
Manufactured preparations use authenticated bark and an extraction process selected to recover a particular chemical fraction. The solvent and drug-to-extract ratio are part of the product specification. A traditional water preparation, raw bark powder and a defined lipophilic extract cannot be assumed to contain equivalent constituents. [Sources]
Scientific evidence & limitations
The EMA dossier provides the basis and limits of conclusions about the preparations it assesses. It does not validate every product labelled “pygeum”. Check the exact extract, study population, comparison and outcomes before applying a finding to a product. [Sources]
Safety & suitability
Urinary difficulty, blood in urine, pain or urinary retention need medical assessment. Do not use a supplement to postpone evaluation of prostate or bladder symptoms. [Sources]
Conservation & knowledge holders
Bark sourcing needs particular care because destructive removal harms long-lived trees. Ask for traceable, responsibly harvested material and current conservation documentation. [Sources]
Sources & credits
Video resources
KTN News Kenya: KEMRI medicinal-plant research (23 March 2026). This is related research news, not a demonstration for this species.
Search YouTube for Prunus africana. These search results are uncurated; check identity, credentials and evidence before relying on a video.